Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assist. Prof. Dr. Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Petra University, Jordan

Dr. Dania Alhyari is an accomplished pharmaceutical sciences researcher and assistant professor with over a decade of experience in academia, research, and mentorship. Her expertise lies in drug formulation, permeability, solubility, and phytochemistry, with a strong focus on enhancing drug bioavailability and therapeutic efficacy. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, and a Master’s in Molecular Biology from the University of Ottawa, Canada. Throughout her career, she has been actively involved in teaching and research, currently serving as an Assistant Professor at Petra University, Jordan, where she mentors graduate students and leads research projects on novel drug delivery systems. Previously, she was a Postdoctoral Fellow at the University of Bradford, where she collaborated on interdisciplinary research and presented findings at international conferences. Dr. Alhyari has published extensively in reputed journals, contributing to advancements in pharmaceutical sciences. Her work emphasizes the integration of molecular biology with drug formulation to optimize therapeutic outcomes. She has also received recognition for her academic contributions, including invitations to speak at conferences and research grants for her studies. With a strong background in teaching, research, and international collaboration, Dr. Alhyari continues to make significant contributions to pharmaceutical innovation.

Professional Profile

Education

Dr. Dania Alhyari holds a strong academic background in pharmaceutical sciences and molecular biology, which has shaped her expertise in drug formulation and biopharmaceutical research. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, where she focused on drug permeability and solubility studies, developing innovative methodologies to enhance drug bioavailability. Her doctoral research involved interdisciplinary collaborations and was presented at several international conferences. Prior to her Ph.D., she completed a Master’s degree in Molecular Biology at the University of Ottawa, Canada, where she gained in-depth knowledge of biochemical and genetic interactions related to pharmaceutical applications. During her master’s studies, she engaged in extensive laboratory work, investigating drug interactions at the molecular level. Her academic journey began with a Bachelor’s degree in Pharmacy, where she developed a solid foundation in drug formulation, pharmacokinetics, and analytical techniques. Throughout her education, Dr. Alhyari actively participated in research projects, contributing to publications and advancing pharmaceutical knowledge. Her diverse educational background, spanning pharmacy, molecular biology, and pharmaceutical sciences, has provided her with a multidisciplinary perspective that enhances her research capabilities. With a commitment to scientific discovery, her education has been instrumental in shaping her career in academia and pharmaceutical research.

Professional Experience

Dr. Dania Alhyari has amassed extensive professional experience in pharmaceutical research and academia, contributing significantly to drug formulation, solubility, and permeability studies. She currently serves as an Assistant Professor at Petra University, Jordan, where she teaches advanced courses in pharmaceutics and pharmaceutical technology while mentoring graduate students in innovative drug delivery research. In this role, she leads research projects exploring novel drug formulations and collaborates with international experts to enhance pharmaceutical applications. Prior to this, she worked as a Postdoctoral Fellow at the University of Bradford, UK, where she developed cutting-edge methodologies for drug permeability and solubility studies. During her postdoctoral tenure, she mentored students, presented her findings at international conferences, and worked closely with interdisciplinary teams to advance pharmaceutical research. Earlier in her career, Dr. Alhyari served as a Research and Teaching Assistant at Petra University, where she played a key role in curriculum development, laboratory research, and student mentorship. She co-authored multiple research papers and contributed to the design of laboratory experiments that enhanced the university’s pharmaceutical research capabilities. Her professional journey reflects a strong balance between research, teaching, and leadership, positioning her as a key contributor to the advancement of pharmaceutical sciences and education.

Research interest

Dr. Dania Alhyari’s research interests lie at the intersection of drug formulation, permeability, solubility, and phytochemistry, with a focus on optimizing drug delivery systems for improved therapeutic outcomes. She is particularly interested in enhancing the bioavailability of pharmaceutical compounds by studying their physicochemical and biopharmaceutical properties. Her work explores innovative drug delivery mechanisms, including novel excipients, nanoformulations, and targeted drug transport to improve drug absorption and efficacy. Additionally, she investigates the role of natural compounds in pharmaceutical sciences, studying their antioxidant, anti-inflammatory, and bioavailability-enhancing properties. Through interdisciplinary collaborations, she integrates molecular biology techniques with pharmaceutical sciences to better understand drug interactions at the cellular and molecular levels. Dr. Alhyari is also passionate about the development of more efficient and patient-friendly pharmaceutical formulations, ensuring safer and more effective therapeutic interventions. Her research extends to the evaluation of drug-excipient interactions, solubility enhancement strategies, and the design of pharmaceutical formulations that cater to specific medical needs. By combining experimental research with advanced analytical techniques, she aims to contribute to the evolution of drug development and pharmaceutical innovation. Her research efforts have been recognized through publications in high-impact journals and presentations at international conferences.

Award & Honor

Dr. Dania Alhyari has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences, research, and education. Her dedication to advancing drug formulation and delivery systems has earned her invitations to present her findings at prestigious international conferences, where she has been acknowledged for her innovative research. She has also secured research grants that have supported her studies in drug permeability, solubility enhancement, and pharmaceutical applications, further demonstrating the significance of her work. Throughout her academic career, she has been recognized for excellence in teaching and mentorship, guiding both undergraduate and graduate students in pharmaceutical research. Her contributions to scientific literature, including publications in high-impact journals, have been widely cited, highlighting the relevance of her research in the global pharmaceutical community. Additionally, she has collaborated with leading researchers from renowned institutions in the UK and Canada, receiving commendations for her interdisciplinary work in pharmaceutical sciences and molecular biology. Dr. Alhyari’s commitment to research excellence, innovation, and education continues to be acknowledged through various accolades, reinforcing her position as a leading researcher in her field. Her achievements reflect her dedication to pushing the boundaries of pharmaceutical research and inspiring future scientists.

Conclusion

Dania Alhyari is a strong candidate for the Best Researcher Award due to her research output, international collaborations, and academic contributions. However, strengthening aspects like grant funding, patents, and research impact metrics would further solidify her case.

Publications Top Notes

  • Physicochemical and biopharmaceutical characterization of new sulfonamide derivatives of gallic acid

    • Author(s): D. Alhyari, H. Sheldrake, S. Kantamneni, M. Isreb, S.J. Soumehsaraei, et al.

    • Year: 2022

    • Citations: 4

  • Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid

    • Author(s): D. Alhyari, N.A. Qinna, H.M. Sheldrake, S. Kantamneni, B.Y. Ghanem, et al.

    • Year: 2025

    • Citations: Not available yet (recent publication)

  • Physicochemical and biopharmaceutical characterization of novel derivatives of gallic acid

    • Author(s): D.H. Alhyari

    • Year: 2022

    • Citations: Not available (Thesis/Dissertation)